ReviewInternational journal of molecular sciences2024

Tyrosine Hydroxylase Inhibitors and Dopamine Receptor Agonists Combination Therapy for Parkinson's Disease.

Ling Xiao Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.